Robert Schooley, M.D., Joins Vertex Scientific Advisory Board
Contact: Stephanie K. Marrus Director, Corporate Communications (617) 499-2490 Robert Gottlieb Senior Vice President, Feinstein Partners Inc. (617) 577-8110 Robert Schooley, M.D., Joins Vertex Scientific Advisory Board Cambridge, MA, July 8, 1993. Robert Turner Schooley, M.D., has joined the Scientific Advisory Board of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Dr. Schooley is a leading clinician and researcher in the field of virology with particular expertise with the Human Immunodeficiency Virus (HIV) and AIDS. He is presently Director of the Infectious Disease Division of the University of Colorado Health Sciences Center, where his laboratory is investigating pathogenesis of HIV and herpes group viruses. Dr. Schooley is also Professor of Medicine at the University and Staff Physician for the Denver Veterans Affairs Medical Center. Dr. Vicki Sato, Vertex's Vice President of Research, Chief Scientific Officer and Chair of the Scientific Advisory Board, remarked, "Dr. Schooley brings to Vertex a wealth of clinical and research expertise in the development of new drugs to treat significant viral diseases. We expect that Dr. Schooley, as a leading authority on AIDS and retroviral infection, will make important contributions to our antiviral programs, particularly as our compounds move towards clinical trials." Dr. Schooley chairs the Immunology Committee of the National Institutes of Health (NIH) AIDS Clinical Trials Group, which oversees immune therapeutic efforts in AIDS, and is a member of the AIDS and Related Retroviruses I Study Section of the NIH, which reviews grants for investigators working in the HIV area. Prior to his appointments in Colorado, Dr. Schooley was Associate Professor of Medicine at the Harvard Medical School and practiced at the Massachusetts General Hospital, where he directed the Fellowship Program for the Infectious Disease Unit and served as Acting Director of the AIDS Clinical Trials Group. - more - Vertex Pharmaceuticals Incorporated11I 111IlilhIIIU1II 40 Allston Street Cambridge, MA 02139-4211 5571095.0291.042 Tel: 617-576-3111 Fax: 617-576-2109
About this Item
- Title
- Robert Schooley, M.D., Joins Vertex Scientific Advisory Board
- Author
- Vertex Pharmaceuticals Incorporated
- Canvas
- Page 1 - Title Page
- Publication
- 1993-07-08
- Subject terms
- press releases
- Series/Folder Title
- Disease Management > AIDS Treatment > Pharmaceutical Treatment > General
- Item type:
- press releases
Technical Details
- Collection
- Jon Cohen AIDS Research Collection
- Link to this Item
-
https://name.umdl.umich.edu/5571095.0291.042
- Link to this scan
-
https://quod.lib.umich.edu/c/cohenaids/5571095.0291.042/1
Rights and Permissions
The University of Michigan Library provides access to these materials for educational and research purposes, with permission from their copyright holder(s). If you decide to use any of these materials, you are responsible for making your own legal assessment and securing any necessary permission.
Related Links
IIIF
- Manifest
-
https://quod.lib.umich.edu/cgi/t/text/api/manifest/cohenaids:5571095.0291.042
Cite this Item
- Full citation
-
"Robert Schooley, M.D., Joins Vertex Scientific Advisory Board." In the digital collection Jon Cohen AIDS Research Collection. https://name.umdl.umich.edu/5571095.0291.042. University of Michigan Library Digital Collections. Accessed May 10, 2025.